Polaryx Therapeutics, Inc. 8-K

What Happened

• Polaryx Therapeutics, Inc. (PLYX) announced in an 8-K filed July 17, 2026 that its Board determined the 2026 Annual Meeting of Stockholders will be held virtually on September 10, 2026. The Board made the determination on July 16, 2026 and said additional meeting details and matters to be voted on will be provided in the company’s proxy statement to be filed with the SEC before the meeting.

Key Details

• Annual Meeting date: September 10, 2026 (virtual).
• Record date and proposal deadline: stockholders of record at close of business on July 27, 2026 will be entitled to notice and to vote; that same date is the deadline to submit proposals for inclusion in the proxy under Rule 14a-8.
• Delivery address for shareholder proposals/nominations: Alex Yang, South Tower, 140 E Ridgewood Avenue, Suite 415, Paramus, NJ 07652 (must be received by close of business on July 27, 2026).
• The Company reserves the right to change the record date, meeting date, or meeting location prior to the Annual Meeting; any nominations/proposals must also comply with SEC rules, Nevada corporate law, and the Company’s bylaws.

Why It Matters

• Investors who want to vote at the 2026 Annual Meeting must be holders of record by the July 27, 2026 record date. Shareholders wishing to submit proposals or nominate directors for inclusion in Polaryx’s proxy materials must meet the July 27 deadline and relevant legal/bylaw requirements—late submissions will not be included or considered at the meeting. This filing provides scheduling and procedural deadlines that affect shareholder voting and governance participation.